Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and nab-Paclitaxel in Locally Advanced and Inflammatory TNBC
NCT01525966Phase 2Active, not recruiting
- Sponsor
- City of Hope
- Start
- Mar 2012
- Primary completion
- Jan 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in triple-negative breast cancer (TNBC), sponsored by City of Hope. Started Mar 2012; status: active, not recruiting.
02
Drugs
carboplatinpaclitaxel
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01525966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525966.